Filing Flows › GSK (GSK) › Q2 2026 › vs Q1 2026
GSK (GSK) Q2 2026 vs Q1 2026 (quarter over quarter)
GSK's revenue rose $470M (+6%) from $7.5B in Q1 2026 to $8.0B in Q2 2026. Gross margin 72.9% against 74.2% (-1.3 pts).
GSK, Q2 2026: revenue $8.0B, operating margin 25.3%, net earnings $1.4B. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 72.9% | 74.2% | -1.3 pts |
| Operating margin | 25.3% | 29.5% | -4.2 pts |
| Net margin | 18.1% | 21.6% | -3.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $8.0B | $7.5B | $470M | +6% |
| Gross profit | $5.8B | $5.6B | $242M | +4% |
| Cost of revenue | $2.2B | $1.9B | $228M | +12% |
| Operating profit | $2.0B | $2.2B | −$193M | -9% |
| Operating expenses | $3.8B | $3.4B | $435M | +13% |
| Pre-tax earnings | $1.9B | $2.1B | −$221M | -10% |
| Other expense, net | $136M | $108M | $28.0M | +26% |
| Research & development | $2.0B | $1.5B | $562M | +38% |
| Other operating costs | $1.8B | $1.9B | −$127M | -7% |
| Net earnings | $1.4B | $1.6B | −$181M | -11% |
| Minority interests | $203M | $148M | $55.0M | +37% |
| Income tax | $241M | $336M | −$95.0M | -28% |
Questions
How much did GSK's revenue grow quarter over quarter in Q2 2026?
GSK's revenue rose $470M (+6%) from $7.5B in Q1 2026 to $8.0B in Q2 2026. Gross margin 72.9% against 74.2% (-1.3 pts).